Sherief Abd-Elsalam
Tanta, Egypt
Location status: Recruiting
Location contact
Sherief Abd-Elsalam
CONTACT
NCT Number: NCT04168099
oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Tanta, Egypt
Location status: Recruiting
Sherief Abd-Elsalam
CONTACT
Comparative Study between the Efficacy of oral Gemifloxacin and intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cefotaxime IV
Other names: cefotax, claforan
Gemifloxacin oral
Other names: gemiflox
Time frame: 6 months
the total number of patients with resolution of infection
Contact information is provided by the study sponsor or research team.
Sherief Abd-Elsalam, ass. prof.
CONTACT
sherief abd-elsalam, ass. prof.
CONTACT
Tanta University
Other
Comparative Study Between the Efficacy of Oral Gemifloxacin and Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06026267
Digestive System Diseases, Fibrosis
New Delhi, National Capital Territory of Delhi, India
View Trial DetailsNCT04161768
Spontaneous Bacterial Peritonitis
Tanta, Egypt
View Trial DetailsNCT04153604
Cirrhosis, Fibrosis
Dallas, Texas, United States
View Trial DetailsNCT07024355
Spontaneous Bacterial Peritonitis
View Trial Details